Long-term Forecasting


Forecasting can make or break a company. This is why it's critical to develop an accurate forecast that estimates how your drug will perform in the market.

KMK brings considerable expertise and technological skills to the table so you can feel confident about the forecast we develop together.

KMK works with your brand experts on key assumptions to gather your in-depth market knowledge before we draw upon our extensive industry experience to investigate and research your specific brands and markets. Then, we work with the most applicable forecasting model and make “on the fly” variations on assumptions where necessary.

The end result is a forecast that gives you different levels of confidence, not just one, so you have the flexibility to adapt based on the latest market conditions.

Are you ready to forecast with confidence?

Related insights

How To Avoid Costly Mistakes In Pre-launch?

Data Assessment In Action

The Art of Building a Flexible Sales Force During COVID-19

Localizing Your BioPharma Commercial Strategy

The Ultimate Plan for Strong Analytics Support to Drive Business Decisions : A no-compromise solution on quality and value

A Roadmap to Success: Five Guiding Principles to Incentive Compensation Planning

Pharma Companies’ Sales Reporting Efforts Often Fall Short. A look at why this occurs and how to avoid it in the future.

KMK Value Based Medicine

Unlock forward looking Insights via Machine Learning

Genentech, Pfizer and Merck Identified as the Top Three Companies Driving Therapeutic Innovation in Breast Cancer

Readjusting Your Field Force in the World of COVID-19

How to Reach Oncologists when Face-to-Face Interaction is Impossible

High Cost of Medication Tops the List of Challenges for Gastroenterologists Treating IBS

What are the most important asthma products and what makes them superior?

KMK’s Split Credit Tool Improves IC Performance

KMK’s Employee Performance Tool Streamlines HQ/Sales Rep Calibration

Field Force Re-Optimization in Anticipation of Loss of Exclusivity (LOE)

IC Plan Design in Defense of Competitive Entry

Sales Force Effectiveness for Top 20 Pharma